Tomkins, O., Giles, H., Pratt, G., Kishore, B., Seymour, F., Devi, K., Agbuduwe, C., Alnashaba, F., Creasey, T., Ziegler, E., Feixas, P. T., Bailey, K., Smith, D., Gokkel, E., Ramasamy, K., Bygrave, C., Mehrjou, G., Jenner, M., Butt, A., King, A., De-Silva, D., Willis, F., Sachedina, S., Ziller, C., Lindsay, J., Robertson, K., Lavallade, H. D., Sachchithanantham, S., Kohli, N., Kazmi, M., Streetly, M., Warcel, D. (2025). Elranatamab for relapsed/refractory multiple myeloma – multi-centre real-world outcomes from the United Kingdom. Blood. https://doi.org/10.1182/blood-2025-4045